Skip to main content
. Author manuscript; available in PMC: 2021 Jun 21.
Published in final edited form as: Atherosclerosis. 2021 Mar 26;326:56–62. doi: 10.1016/j.atherosclerosis.2021.03.018

Table 3.

ASCVD and CHD Outcomes According to CAC Status Among Statin-Eligible Participants

Outcome Hazard Ratio (95% CI) P-value
All ASCVD
Model 1 0.50 (0.28, 0.89) 0.02
Model 2 0.49 (0.27, 0.90) 0.02
Coronary Heart Disease
Model 1 0.20 (0.07, 0.59) 0.003
Model 2 0.21 (0.07, 0.62) 0.005

Model 1: adjusted for age, sex, race.

Model 2: adjusted for age, sex, race, educational attainment, income, body mass index, total cholesterol, HDL-C, fasting blood glucose, systolic blood pressure, diastolic blood pressure, cigarette smoking, blood pressure-lowering medication, and glucose-lowering medication.

ASCVD-atherosclerotic cardiovascular disease CAC=coronary artery calcium.